Phoenix Children's Hospital receives grant for its Connected Patient Project

Phoenix Children's Hospital has received a $200,000 grant that will support the hospital's "Connected Patient Project," which provides customized patient care information on tablets.

Phoenix Children's Hospital uses Journey Boards as tools to help families of a sick child identify what they need to know before taking their child home from the hospital. Parts of the Journey Board may also be applied to a clinic or emergency room visit.

The hospital is currently using print versions of the Journey Board. Through the grant, this information will be delivered utilizing technology, with 200 tablets being installed in patient rooms with interactive, customized content. The project will benefit 13,000 patients annually.

The grant is from the James M. Cox Foundation grant. Cox Communications is also funding the creation of 21 Journey Board apps, available in English and Spanish.

"For families, hospital stays can be a very intense and stressful time and it can be hard to retain information under those conditions," said Teresa Boeger, director, Division of Family Centered Care at Phoenix Children's Hospital. "Journey Boards help us ensure that comprehension is taking place and helps us identify gaps in understanding."

Phoenix Children's Hospital is Arizona's only licensed children's hospital and among the largest freestanding facilities of its kind in the country, with 385 licensed beds. The hospital operates six satellite centers.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.